Spravato

What Is Spravato

Spravato is a nasal spray version of Ketamine that was FDA-approved for the treatment of depression symptoms in 2019. Whereas IV Ketamine includes a mixture of both “R” and “S” mirror-image versions of the Ketamine molecule, Spravato delivers just the “S” version. Like I.V. Ketamine, Spravato has been shown to improve the symptoms of depression which has been resistant to traditional medical treatments. Spravato works in the much same way as IV Ketamine but instead of receiving the medication from an I.V. line, the patient uses a nasal spray. Both medications must be taken at a certified medical facility under the supervision of a healthcare provider.